Anthrax		HPV		Pertussis		Rubella
Chickenpox (varicella)		Influenza - H1N1		PCV7		Shingles (zoster)
Diphtheria		Influenza (seasonal)		PPSV		Smallpox
Hepatitis A		Measles		Polio		Tetanus
Hepatitis B		Meningococcus		Rabies
Hib		Mumps		Rotavirus

Meningococcus archive 2003-1997

Meningococcus 2009

Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease Source: MMWR, September 25, 2009, Vol. 58(37):1042-3

HTML  |  PDF (entire issue)

National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years--United States, 2008 Source: MMWR, September 18, 2009, Vol. 58(36):997-1001

HTML  |  PDF (entire issue)

Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America Authors: Pickering LK, Baker CJ, Freed GL, et al. Source: Clin Infect Dis, September 15, 2009, Vol. 49(6):817-40

Abstract

Increasing Adolescent Vaccination: Barriers and Strategies in the Context of Policy, Legal, and Financial Issues Authors: Ford CA, English A, Davenport AF, Stinnett AJ Source: J Adolesc Health, June 2009, Vol. 44(6):568-74

Abstract

State-Based Surveillance to Determine Trends in Meningococcal Disease Authors: Clarke C, Mallonee S Source: Public Health Rep, March-April 2009, Vol. 124(2):280-7

Abstract

Outcomes of Meningococcal Disease in Adolescence: Prospective, Matched-Cohort Study Authors: Borg J, Christie D, Coen P, Booy R, Viner R Source: Pediatrics, March 2009, Vol. 123(3):e502-509

Abstract

Completeness and Timeliness of Reporting of Meningococcal Disease--Maine, 2001-2006 Source: MMWR, February 27, 2009, Vol. 58(07):169-172

HTML  |  PDF (entire issue)

back to top

Meningococcus 2008-2007

Meningococcal Tetravalent Conjugate Vaccine Author: Smith MJ Source: Expert Opin Biol Ther, December 2008, Vol. 8(12):1941-6

Abstract

Report from the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4) Authors: Centers for Disease Control and Prevention Source: MMWR, May 2, 2008, Vol. 57(17):462-5

HTML  |  PDF (entire issue)

Risk Factors for Meningococcal Disease in Students in Grades 9-12 Authors: Harrison LH, Kreiner CJ, Shutt KA Source: Pediatr Infect Dis J, March 2008, Vol. 27(3):193-9

Abstract

New, and Some Not-So-New, Vaccines for Adolescents and Diseases They Prevent Authors: Fishbein DB, Broder KR, Markowitz L, Messonnier N Source: Pediatrics, January 2008, Vol.121 Suppl 1:S5-14

Abstract

Economics of an Adolescent Meningococcal Conjugate Vaccination Catch-Up Campaign in the United States Authors: Ortega-Sanchez IR, Meltzer MI, Shepard C Source: Clin Infect Dis, January 1, 2008, Vol. 46(1):1-13

Abstract

Mass Antibiotic Treatment to Stop an Outbreak of Meningococcal Disease: A Molecular Analysis Authors: Katz LH, Zelazny A, Scharf S, et al Source: Clin Microbiol Infect, September 2007; 13(9):943-946

Abstract

Notice to Readers: Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine Source: MMWR, August 10, 2007; 56(31):794-795

HTML |  PDF (entire issue)

Meningococcal Vaccines: To Eradicate the Disease, not the Bacterium Authors: Taha MK, Alonso JM Source: Hum Vaccin, July-August 2007; 3(4):149-153

Abstract

Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight-Year Longitudinal Study in Northern Ghana Authors: Leimkugel J, Hodgson A, Forgor AA, et al Source: PLoS Med, March 27, 2007; 4(3):e101

Abstract

back to top

Meningococcus 2006

General Recommendations on Immunization Source: MMWR, December 1, 2006; 55(RR-15):1-48

HTML |  PDF (entire issue)

Notice to Readers: Recommendation to resume meningococcal vaccination of children aged 11-12 years MMWR, November 3, 2006, Vol. 55(43):1177

HTML |  PDF (entire issue)

Prevention of Meningococcal Disease Author: Gardner P Source: N Engl J Med, October 5, 2006, Vol. 355: 1466-1473 Click here for free full-text article

PDF

Multicenter Surveillance of Invasive Meningococcal Infections in Children Authors: Kaplan SL, Schutze GE, Leake JA, et al Source: Pediatrics, October 2006, Vol. 118(4):e979-984

Abstract

Inadvertent Misadministration of Meningococcal Conjugate Vaccine --- United States, June--August 2005 Source: MMWR, September 22, 2006, Vol. 55(37):1016-1017

HTML |  PDF (entire issue)

Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11--12 Years Source: MMWR, May 26, 2006 Vol. 55(20):567-568

HTML |  PDF (entire issue)

Update: Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, October 2005--February 2006 Source: MMWR, April 7, 2006, Vol. 55(13):364-366

HTML

Antibody Persistence 3 Years after Immunization of Adolescents With Quadrivalent Meningococcal Conjugate Vaccine Authors: Mitchell P, Dela Cruz JV, Granoff DM et al Source: J Infect Dis, March 15, 2006, Vol. 193(6):821-882

Abstract

Population-Based Analysis of Meningococcal Disease Mortality in the United States: 1990-2002 Authors: Sharip A, Sorvillo F, Redelings MD, et al Source: Pediatr Infect Dis J, March 2006, Vol. 25(3):191-194

Abstract

back to top

Meningococcus 2005

Prevention of Meningococcal Disease Author: Kimmel SR Source: Am Fam Physician, Nov. 15, 2005, Vol. 72(10):2049-2056

Abstract

Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine --- United States, June--July 2005 Source: MMWR, October 14, 2005, Vol. 54(40):1023-1025

HTML

Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21

PDF

Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients Source: American Academy of Pediatrics, May 25, 2005

PDF

Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States Authors: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, et al Source: Pediatrics, May 2005, Vol. 115(5):1220-1232

Abstract

Meningococcal Vaccine: New Product, New Recommendations Author: Campos-Outcalt D Source: J Fam Pract, April 2005, Vol. 54(4):324-326

Abstract

Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-year-old Children Authors: Pichichero M, Casey J, Blatter M, et al Source: Pediatr Infect Dis J, January 2005, Vol. 24(1):57-62

Abstract

back to top

Meningococcus 2004

Global Epidemiology of Meningococcal Disease and Vaccine Efficacy Author: Pollard AJ Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S274-S279

Abstract

Meningococcal C Vaccines: The Canadian Experience Author: De Wals P Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S280-S284

Abstract

Meningococcal Vaccines Author: Danzig L Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S285-S292

Abstract

The Strategy to Control New Zealand's Epidemic of Group B Meningococcal Disease Authors: O'Hallahan J, Lennon D, Oster P Source: Pediatr Infect Dis J, December 2004, Vol. 23(12):S293-S298

Abstract

Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States Authors: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, et al Source: Pediatrics, May 2005, Vol. 115(5):1220-1232

Abstract

The Rhode Island Meningitis Vaccine Experience--Mass Vaccination Campaigns, Politics and Health Policy Author: Nolan P Source: Med Health R I, March 2004, Vol. 87(3):65-67

Abstract

Opportunities for Control of Meningococcal Disease in the United States Authors: Raghunathan PL, Bernhardt SA, Rosenstein NE Source: Annu Rev Med, 2004, Vol. 55:333-353

Abstract

back to top

Meningococcus Archive

Meningococcus journal articles 2003-1991